WA
TEVA icon

WBH Advisory’s Teva Pharmaceuticals TEVA Stock Holding History

WBH Advisory’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,794
Closed -$224K – 205
2015
Q2 		$224K Hold
3,794
– – 0.09% 183
2015
Q1 		$236 Sell
3,794
-50
-1% -$2.91K 0.07% 186
2014
Q4 		$221K Sell
3,844
-200
-5% -$11.1K 0.08% 188
2014
Q3 		$217K Buy
4,044
+66
+2% +$3.5K 0.08% 196
2014
Q2 		$208K Hold
3,978
– – 0.08% 201
2014
Q1 		$210K Buy
+3,978
New +$184K 0.08% 201
2013
Q4 		– Sell
-7,150
Closed -$270K – 205
2013
Q3 		$270K Sell
7,150
-550
-7% -$21.5K 0.12% 160
2013
Q2 		$301K Buy
+7,700
New +$300K 0.14% 149

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBH Advisory's TEVA Position: Q3 2015 in Review

WBH Advisory sold out of Teva Pharmaceuticals (TEVA) in Q3 2015, closing a stake of 3,794 shares — an estimated $224K sold.

WBH Advisory first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $301K in Q2 2013. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

  • WBH Advisory reported no remaining Teva Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • WBH Advisory sold 3,794 Teva Pharmaceuticals shares in Q3 2015, an estimated $224K.
  • WBH Advisory first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • WBH Advisory's Teva Pharmaceuticals position peaked at $301K in Q2 2013.
  • 823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on WBH Advisory's 13F filing for Q3 2015, filed 15 Oct 2015.